Johnson & Johnson

NYSE: JNJ
$160.09
-$1.51 (-0.9%)
Closing Price on October 29, 2024

JNJ Articles

24/7 Wall St. has put together a preview of GE, IBM and the other Dow Jones Industrial Average companies scheduled to report their quarterly results this week.
Here are seven companies that have 50 straight years or more of raising their dividends, as well as several runners-up.
The top analyst upgrades, downgrades and other research calls from Thursday include Albermarle, American Airlines, Ellie Mae, Johnson & Johnson, Mallinckrodt, Mylan, NetApp and Southwest Airlines.
Nike, UnitedHealth, DowDuPont, and Johnson & Johnson were among the Dow's best performing stock's Tuesday.
The eight worst performing Dow stocks for 2018 have all lost at least 10% of their value for the year to date.
The Dow wobbled around Thursday and looks set to close very near the break-even line as J&J, Pfizer, Caterpillar, and McDonald's pushed higher.
Here are 10 defensive stocks, including Verizon Communications and Coca-Cola, trading higher during this latest market sell-off.
Pfizer, UnitedHealth, Disney, and Johnson & Johnson lifted the DJIA on Friday.
24/7 Wall St. has tracked many of the so-called whale watching trades made by America's top investment managers, hedge fund managers and independent investors.
Over the course of the last few trading days, we have seen the return of volatility and some serious carnage in the markets. To kick off this week, the Dow Jones Industrial Average dropped 1,175...
Theravance Biopharma shares made a solid gain on Wednesday after the company announced a global collaboration with Janssen Biotech.
24/7 Wall St. is addressing some of the top market darlings and most widely held stocks by the public. We looked at how the drop was on Monday and how the shares were indicated to open on Tuesday.
24/7 Wall St. has chosen a list of companies that will operate fine in times of market turmoil and probably will operate well from financial standpoint even if economic turmoil were to arise.
Chevron, Exxon, 3M, and Johnson & Johnson led all 30 DJIA stocks on a second-consecutive unanimous tumble.
24/7 Wall St. has included a calendar of a some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February.